Agenus Inc
AGEN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001098972
No open-market purchases or sales by Agenus Inc insiders were filed in the last 90 days; 103 institutions reported holding it in 13F filings for Q2 2026, worth $43.6M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Agenus Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Agenus Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Marcucci Marco Tullio | Director | – | Sep 16, 2026 | 1 |
| Armen Garo H | See Remarks | 371,108 | Aug 12, 2026 | 23 |
| Harrison Thomas L | Director | 47,545 | Aug 11, 2026 | 6 |
| Corvese Brian | Director | – | Aug 11, 2026 | 2 |
| Wright Timothy | Director | – | Aug 7, 2026 | 6 |
| O'Day Steven J | Chief Medical Officer | 57,116 | Aug 7, 2026 | 2 |
| Hirsch Susan B | Director | 108,725 | Aug 7, 2026 | 2 |
| Buell Jennifer | See Remarks | 19,738 | Aug 7, 2026 | 2 |
| Charette Austin | Principal Accounting Officer | – | Apr 28, 2026 | 1 |
| Klaskin Christine M | PFO & PAO | 23,478 | Jun 30, 2025 | 0 |
| Wiinberg Ulf | Director | 124,063 | Oct 3, 2024 | 0 |
| Jeynes-Ellis Allison M | Director | – | Apr 22, 2024 | 0 |
| Jordan Wadih | Director | – | Oct 5, 2022 | 0 |
| Krauss Adam | Chief Legal Officer | – | Jul 2, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2024 (view filing) | Feb 15 | Same day | Armen Garo HSee Remarks | PPurchase | +500.0K | $0.65 | +$325.0K | +396.9%626.0K after | |
| Nov 17, 2023 (view filing) | Nov 15 | 2 days | Wiinberg UlfDirector | PPurchase | +25.0K | $0.76 | +$19.0K | +25.2%124.1K after | |
| Jan 6, 2022 (view filing) | Jan 6 | Same day | O'Day Steven JChief Medical Officer | SSale | −38.7K | $3.06 | −$118.4K | −38.7%61.3K after | |
| Sep 14, 2021 (view filing) | Sep 13 | 1 day | Armen Garo HChairman and CEO | SSale | −82.1K | $6.50 | −$533.7K | −9.6%770.8K after | |
| Sep 14, 2021 (view filing) | Sep 10 | 4 days | Klaskin Christine MPFO & PAO | SSale | −11.1K | $6.50 | −$72.3K | −10.7%93.1K after |